The effect of sustained release hexocyclium tablets on gastric acid secretion.
D003692:Delayed-Action Preparations; D004381:Duodenal Ulcer / Q000188:drug therapy; D005745:Gastric Acidity Determination; D005750:Gastric Juice / Q000187:drug effects / Q000378:metabolism*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*; D013608:Tablets, Enteric-Coated
D003692:Delayed-Action Preparations; D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D010879:Piperazines; D000644:Quaternary Ammonium Compounds; D013608:Tablets, Enteric-Coated